Monash chemistry focus
January 15, 2013
PHARMACY students at Monash
University will now be able to make
use of a new the Translational
Medicinal Chemistry Facility at the
University's Parkville campus.
The new facility is the result of a
collaborative partnership between
Monash Institute of Pharmaceutical
Sciences, the Federal and Victorian
Governments, and private industry
“to enhance Australia's translational
medicinal chemistry drug
development capabilities”.
The facility is housed in new,
dedicated and well-equipped
laboratories and is co-located with
the Centre for Drug Candidate
Optimisation, which has
collaboratively supported the
translation of 16 drug candidates
into clinical evaluation.
“Collaborative research between
chemists, biologists and
pharmaceutical scientists is
essential to translate innovative
research insights into high value,
clinically relevant products and new
medicines,” said Director of MIPS
and Dean of the Faculty of
Pharmacy and Pharmaceutical
Sciences, Professor Bill Charman.
“Our strengths are in structurebased
drug design and synthetic
medicinal and organic chemistry.
“Our researchers apply these
chemical principles and techniques
to the discovery and development
of compounds to prevent, treat or
cure disease,” he added.
Charman also added that worldclass
medicinal chemistry was
essential to translate fundamental
biological and chemical insights
into potential drug candidates
destined for pre-clinical and clinical
development.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 13
